SAB Biotherapeutics Inc.
SABS | NASDAQ
$3.49
+$0.10 (+2.95%)
Sep 22, 2026, 12:20 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 8.27M | 20.52M | 10.5M | 29.42M | 3.69M | 5.64M | 8.9M | 9.17M | 17.24M | 14.03M | 56.57M | 2.43M | 7.77M | 13.06M | 15.05M | 8.33M | 16.62M | 22.41M | 33.21M | 10.75M | 10.23M | 858.06K |
Short-Term Investments | 94.37M | 86.87M | 86.09M | 81.46M | 2.02M | 7.21M | 11.86M | 21.23M | 20.08M | 30.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 105.35M | 110.24M | 46.89M | 50.61M | n/a | n/a | n/a | n/a | n/a | 1.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 116.15M |
Other Long-Term Assets | 5.34M | 5.28M | 5.46M | 124.07K | 417.49K | 449.79K | 482.1K | 514.41K | 521.72K | 554.03K | 350.23K | 371.19K | 434K | 434K | 467.69K | 501.39K | 535.08K | -1 | n/a | n/a | n/a | n/a |
Receivables | 1.84M | 1.56M | 946.78K | 559.95K | n/a | 21.39K | 54.96K | 97.05K | 224.92K | 193.23K | n/a | n/a | 364.12K | 763.12K | 5.56M | 12.94M | 9.61M | 11.79M | 8.01M | 10.21M | 17.11M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.46M | 3.84M | 3.51M | 1.84M | 3.59M | 3.42M | 2.98M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.34M | n/a | n/a | n/a |
Total Current Assets | 107.94M | 112.78M | 101.05M | 113.28M | 9.31M | 16.3M | 23.79M | 32.54M | 39.58M | 46.95M | 58.91M | 3.13M | 9.01M | 15.03M | 22.1M | 22.18M | 27.75M | 36.17M | 50.19M | 21.91M | 27.77M | 1.12M |
Property-Plant & Equipment | 19.58M | 20.17M | 19.4M | 19.44M | 20.4M | 21.37M | 19.92M | 20.75M | 21.79M | 22.63M | 24.68M | 24.84M | 26M | 27.21M | 28.34M | 29.82M | 30.87M | 31.3M | 30.95M | 29.22M | 26.44M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 130.27M | 135.69M | 71.76M | 70.17M | 20.82M | 21.82M | 20.4M | 21.26M | 22.31M | 24.42M | 25.03M | 25.21M | 26.44M | 27.64M | 28.81M | 30.33M | 31.4M | 31.3M | 30.95M | 29.22M | 26.44M | 116.15M |
Total Assets | 238.21M | 248.47M | 172.81M | 183.45M | 30.13M | 38.12M | 44.2M | 53.8M | 61.89M | 71.37M | 83.94M | 28.34M | 35.44M | 42.67M | 50.9M | 52.51M | 59.15M | 67.47M | 81.14M | 51.13M | 54.21M | 117.27M |
Account Payables | 3.86M | 3.54M | 3.15M | 2.95M | 2.62M | 2.52M | 1.69M | 1.3M | 1.17M | 1.24M | 945.93K | 1.08M | 1.4M | 1.44M | 3.68M | 5.48M | 4.94M | 4.98M | 4.46M | 4.12M | 5.5M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 114.7K | 114.7K | 377.84K | 1.32M | 1.63M | 2.89M | 2.94M | n/a | n/a | n/a | n/a | 100K | n/a | 100K | n/a |
Short-Term Debt | 641K | n/a | 951.37K | n/a | n/a | 138.55K | 275.85K | 524.74K | 615.82K | 835.47K | 1.05M | 541.64K | 784.88K | 444.48K | 772.67K | n/a | n/a | n/a | 1.8M | 24.14K | 24.14K | n/a |
Other Current Liabilities | n/a | 386.34K | 1.55M | n/a | n/a | n/a | n/a | n/a | 1.01M | 1.28M | 4.49M | 4.43M | 4.22M | 923.16K | 8.1M | 7.69M | 7.4M | 10.18M | 8.7M | 187.93K | 587.79K | 80K |
Total Current Liabilities | 11.71M | 9.85M | 10.68M | 10.79M | 10.68M | 9.65M | 7.98M | 8.82M | 7.55M | 8.3M | 10.81M | 9.21M | 11.01M | 13.67M | 14.99M | 17.1M | 16.14M | 18.26M | 26.46M | 10.47M | 10.2M | 80K |
Long-Term Debt | 4.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 541.64K | 541.64K | 541.64K | n/a | n/a | n/a | n/a | 25.01K | 25.01K | n/a |
Other Long-Term Liabilities | 7.23M | 6.12M | 5.64M | 2.38M | 1.98M | 1.35M | 6.39M | 4.08M | 4.09M | 6.31M | 11.77M | 417.1K | 595.86K | 238.34K | 320.93K | 357.52K | 1.14M | 2.87M | 10.72M | n/a | n/a | 7.8M |
Total Long-Term Liabilities | 11.72M | 11.37M | 10.63M | 7.58M | 7.44M | 7.06M | 10.25M | 8.08M | 8.22M | 10.24M | 15.83M | 3.87M | 4.72M | 4.6M | 4.85M | 4.78M | 5.9M | 7.96M | 16.14M | 5.58M | 5.76M | 7.8M |
Total Liabilities | 23.43M | 21.22M | 21.32M | 18.37M | 18.11M | 16.71M | 18.23M | 16.89M | 15.77M | 18.55M | 26.64M | 13.08M | 15.73M | 18.27M | 19.85M | 21.88M | 22.03M | 26.21M | 42.59M | 16.05M | 15.95M | 7.88M |
Total Debt | 5.13M | 6.17M | 5.95M | 6.19M | 6.42M | 6.78M | 4.67M | 4.52M | 5.34M | 5.45M | 5.91M | 4.65M | 5.58M | 5.46M | 5.93M | 5.78M | 6.07M | 6.39M | 8.52M | 6.82M | 6.92M | n/a |
Book Value | 214.79M | 227.25M | 151.49M | 165.07M | 12.02M | 21.41M | 25.97M | 36.9M | 46.12M | 52.82M | 57.3M | 15.26M | 19.72M | 24.4M | 31.06M | 30.62M | 37.12M | 41.26M | 38.55M | 35.08M | 38.26M | 109.39M |
Book Value Per Share | 2.69 | 4.24 | 3.18 | 2.12 | 1.29 | 2.30 | 2.80 | 3.99 | 4.98 | 5.72 | 9.67 | 2.91 | 3.91 | 4.84 | 6.16 | 7.12 | 8.63 | 9 | 8.87 | 8.07 | 8.80 | 25.16 |
Common Stock | 8K | 7.58K | 4.77K | 4.76K | 936 | 936 | 935 | 929 | 929 | 929 | 929 | 5.29K | 5.29K | 5.09K | 5.09K | 4.36K | 4.36K | 4.35K | 4.35K | 3.52K | 3.52K | 104.39M |
Retained Earnings | -152.26M | -129.76M | -110.9M | -94.03M | -139.48M | -129.37M | -124.17M | -112.77M | -102.42M | -95.09M | -90.06M | -67.21M | -62.1M | -55.22M | -47.87M | -40M | -32.92M | -28.14M | -29.13M | -17.58M | -13.52M | 2.96M |
Comprehensive Income | -930K | -222.76K | 186.51K | 71.22K | -15.81K | -111.59K | -135.41K | 52.13K | -31.35K | -63.45K | 26.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | n/a |
Shareholders Equity | 214.79M | 227.25M | 151.49M | 165.07M | 12.02M | 21.41M | 25.97M | 36.9M | 46.12M | 52.82M | 57.3M | 15.26M | 19.72M | 24.4M | 31.06M | 30.62M | 37.12M | 41.26M | 38.55M | 35.08M | 38.26M | 109.39M |
Total Investments | 199.71M | 197.11M | 132.98M | 132.06M | 2.02M | 7.21M | 11.86M | 21.23M | 20.08M | 31.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 116.15M |
Add to Watchlist
Select watchlists to add or remove SABS